4.8(top 5%)
impact factor
6.0K(top 5%)
papers
222.1K(top 2%)
citations
162(top 2%)
h-index
4.9(top 5%)
impact factor
7.2K
all documents
236.2K
doc citations
233(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cellsCancer Science20051,680
2Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosisCancer Science20101,180
3Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progressionCancer Science2007722
4Epithelial–mesenchymal transition in cancer development and its clinical significanceCancer Science2010691
5Cell adhesion system and human cancer morphogenesisCancer Science2003654
6Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1Cancer Science2004640
7A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfateCancer Science2003632
8Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?Cancer Science2019614
9Reduced expression of Dicer associated with poor prognosis in lung cancer patientsCancer Science2005573
10Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fishCancer Science2004567
11Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancerCancer Science2007554
12Regulation of cancer cell motility through actin reorganizationCancer Science2005541
13Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesisCancer Science2004540
14Oncolytic virus therapy: A new era of cancer treatment at dawnCancer Science2016527
15Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damageCancer Science2004518
16Emerging roles of long non‐coding RNA in cancerCancer Science2018489
17Cancer/testis (CT) antigens: Potential targets for immunotherapyCancer Science2009478
18Preclinical and clinical studies of anticancer agent‐incorporating polymer micellesCancer Science2009474
19ADAMs in cancer cell proliferation and progressionCancer Science2007472
20Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signalCancer Science2003461
21Role of iron in carcinogenesis: Cancer as a ferrotoxic diseaseCancer Science2009461
22YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity in vitro and in vivoCancer Science2011433
23Clinical significance of macrophage heterogeneity in human malignant tumorsCancer Science2014425
24Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneityCancer Science2016394
25Epidemiology of cholangiocarcinoma: An update focusing on risk factorsCancer Science2010385
26Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteinsCancer Science2007380
27Genetic alterations and signaling pathways in the evolution of gliomasCancer Science2009374
28Mechanism and biological significance of CD44 cleavageCancer Science2004359
29Tumor‐derived spheroids: Relevance to cancer stem cells and clinical applicationsCancer Science2017357
30Functional roles of N‐glycans in cell signaling and cell adhesion in cancerCancer Science2008351
31Tumor hypoxia: A target for selective cancer therapyCancer Science2003329
32Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategyCancer Science2008315
33Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancersCancer Science2008311
34Nectins and nectin-like molecules: Roles in cell adhesion, migration, and polarizationCancer Science2003308
35Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategyCancer Science2016305
36Intracellular zinc homeostasis and zinc signalingCancer Science2008304
37Lipoxygenase‐mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3Cancer Science2017303
38Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancerCancer Science2010302
39Aminopeptidase N (CD13) as a target for cancer chemotherapyCancer Science2011293
40The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-betaCancer Science2005291
41Signal transduction of inflammatory cytokines and tumor developmentCancer Science2006286
42Novel combination of serum microRNA for detecting breast cancer in the early stageCancer Science2016274
43Downregulation of microRNAs‐143 and ‐145 in B‐cell malignanciesCancer Science2007271
44Exosomes in cancer development and clinical applicationsCancer Science2018271
45Salt, salted food intake, and risk of gastric cancer: Epidemiologic evidenceCancer Science2005268
46Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesisCancer Science2008264
47Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibilityCancer Science2011263
48Role of the miR‐106b‐25 microRNA cluster in hepatocellular carcinomaCancer Science2009262
49Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapyCancer Science2006260
50Molecular functions and biological roles of hepatitis B virus x proteinCancer Science2006259